Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Intraoperative Optical Coherence Tomography - an Overview of Current Clinical Data for the Application in the Anterior and Posterior Segments].

Klinische Monatsblatter fur Augenheilkunde·2017

Same author

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.

Eye (London, England)·2017

Same author

[Placenta Growth Factor (PlGF) and Retinal Vascular Diseases--Current Knowledge from Experimental and Clinical Studies].

Klinische Monatsblatter fur Augenheilkunde·2016

Same author

[Reliable UV-light protection in intraocular lenses--scientific rationale and quality requirements].

Klinische Monatsblatter fur Augenheilkunde·2014

Same author

Antivascular endothelial growth factor as an approach for macular edema.

Developments in ophthalmology·2010

Same author

[Oxidative tissue damage].

Klinische Monatsblatter fur Augenheilkunde·2010

Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Measuring the Behavioral Effects of Intraocular Scatter

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

[Blue Light-Filtering IOLs - Currently available data].

¹Augenklinik, Klinikum Karlsruhe. albertjaugustin@googlemail.com

Klinische Monatsblatter Fur Augenheilkunde

|August 14, 2010

Summary

This summary is machine-generated.

Blue light-filtering intraocular lenses may protect the retina from damage, but long-term data on preventing diseases like AMD is still needed. Current studies show good visual outcomes but some concerns about contrast and circadian rhythm effects.

More Related Videos

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

Measuring the Behavioral Effects of Intraocular Scatter

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

Area of Science:

Ophthalmology
Biomedical Engineering
Retinal Science

Context:

Emerging evidence links natural lens removal and retinal photo-oxidative stress to diseases like Age-related Macular Degeneration (AMD).
Unfiltered blue light exposure is a suspected contributing factor to retinal damage.
Blue light-filtering intraocular lenses (IOLs) are increasingly used to mitigate this risk.

Purpose:

To review and summarize current research on the efficacy and safety of blue light-filtering IOLs.
To evaluate experimental and clinical data regarding the impact of these lenses on retinal health and visual function.
To identify gaps in current knowledge, particularly concerning long-term outcomes and circadian rhythm effects.

Summary:

Experimental studies indicate blue light-filtering IOLs significantly reduce blue light transmission, protecting retinal cells and lowering inflammatory markers (e.g., VEGF) compared to UV-filtering lenses.
Clinical data generally supports the compatibility of blue light-filtering IOLs, showing no significant adverse effects on visual acuity, color perception, or patient-reported vision quality.
Some studies report potential drawbacks, including reduced contrast sensitivity and impaired mesopic vision, with theoretical concerns also raised regarding circadian rhythm disruption.

Impact:

Provides a comprehensive overview of the current evidence base for blue light-filtering IOLs.
Highlights the need for further long-term clinical trials to confirm the protective effects against AMD and other retinal diseases.
Informs ophthalmologists and patients about the potential benefits and limitations of these advanced IOLs in managing retinal health post-cataract surgery.